Skip to Main content Skip to Navigation
Master Thesis

Le papillomavirus humain et la vaccination anti-HPV en France : comparaison au système australien et étude mettant en évidence les freins à cette vaccination

Abstract : Papillomavirus is responsible for many pathologies of the skin and mucous membranes including warts, condylomas and a number of cancers: cancers of the cervix, vagina, penis, anus, oropharyngeal cancers. It is estimated that 75% of sexually active men and women will come into contact with this virus during their lifetime. Finally, to prevent contamination by papillomavirus, three HPV vaccines are available in France. However, our anti-HPV coverage is very low compared to other countries in the European Union or Australia. What are the reasons? At first, we will study the papillomavirus, its epidemiology, its infections and treatments. Then we will compare the French HPV vaccination system with the Australian National Immunization Program. In a second step, we developed two surveys intended for the population and health professionals and studied the results in order to identify the different brakes on HPV vaccination in France.
Document type :
Master Thesis
Complete list of metadata

Cited literature [102 references]  Display  Hide  Download

https://dumas.ccsd.cnrs.fr/dumas-02417224
Contributor : Frédérique Gambade <>
Submitted on : Wednesday, December 18, 2019 - 9:46:39 AM
Last modification on : Saturday, January 11, 2020 - 1:28:58 AM
Long-term archiving on: : Thursday, March 19, 2020 - 1:57:16 PM

File

Pharmacie_2019_Farne.pdf
Files produced by the author(s)

Identifiers

  • HAL Id : dumas-02417224, version 1

Collections

Citation

Alice Farne. Le papillomavirus humain et la vaccination anti-HPV en France : comparaison au système australien et étude mettant en évidence les freins à cette vaccination. Sciences du Vivant [q-bio]. 2019. ⟨dumas-02417224⟩

Share

Metrics

Record views

300

Files downloads

1373